Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Vaughan

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2000
Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I studyB S Andersson, T Madden, H T Tran, et al.
Blood|July 15, 1990
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomasJ M Vose, C Peterson, P J Bierman, et al.
Blood|August 15, 1992
OMA-AML-1: a leukemic myeloid cell line with CD34+ progenitor and CD15+ spontaneously differentiating cell compartmentsS J Pirruccello, J D Jackson, M S Lang, et al.
AJR. American Journal of Roentgenology|September 1, 1991
Diffuse pulmonary alveolar hemorrhage after bone marrow transplantation: radiographic findings in 39 patientsR J Witte, J W Gurney, R A Robbins, et al.
The American Journal of Medicine|November 1, 1989
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipientsR A Robbins, J Linder, M G Stahl, et al.
Progress in Clinical and Biological Research|January 1, 1983
Patterns of care in oncology: an approach to medical and utilization auditW P Vaughan, T P Waalkes, R E Lenhard, et al.
Leukemia|October 1, 1988
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10)W P Vaughan, C I Civin, D D Weisenburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's diseaseS Jagannath, J O Armitage, K A Dicke, et al.
The American Journal of Medicine|December 1, 1991
Autologous bone marrow transplantation for patients with relapsed Hodgkin's diseaseJ O Armitage, P J Bierman, J M Vose, et al.
Bone Marrow Transplantation|December 1, 1991
Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapyW P Vaughan, J D Dennison, E C Reed, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2000
Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I studyB S Andersson, T Madden, H T Tran, et al.
Blood|July 15, 1990
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomasJ M Vose, C Peterson, P J Bierman, et al.
Blood|August 15, 1992
OMA-AML-1: a leukemic myeloid cell line with CD34+ progenitor and CD15+ spontaneously differentiating cell compartmentsS J Pirruccello, J D Jackson, M S Lang, et al.
AJR. American Journal of Roentgenology|September 1, 1991
Diffuse pulmonary alveolar hemorrhage after bone marrow transplantation: radiographic findings in 39 patientsR J Witte, J W Gurney, R A Robbins, et al.
The American Journal of Medicine|November 1, 1989
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipientsR A Robbins, J Linder, M G Stahl, et al.
Progress in Clinical and Biological Research|January 1, 1983
Patterns of care in oncology: an approach to medical and utilization auditW P Vaughan, T P Waalkes, R E Lenhard, et al.
Leukemia|October 1, 1988
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10)W P Vaughan, C I Civin, D D Weisenburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's diseaseS Jagannath, J O Armitage, K A Dicke, et al.
The American Journal of Medicine|December 1, 1991
Autologous bone marrow transplantation for patients with relapsed Hodgkin's diseaseJ O Armitage, P J Bierman, J M Vose, et al.
Bone Marrow Transplantation|December 1, 1991
Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapyW P Vaughan, J D Dennison, E C Reed, et al.
Pageof 9